Different Aetiology of Familial Low-grade and High-grade Glioma? A Nationwide Cohort Study of Familial Glioma
Overview
Public Health
Affiliations
An increased risk for first-degree relatives (FDR) of glioma patients has previously been observed. The novel objective of this study was to investigate differences in familial risk among FDR of low-grade glioma (LGG) and high-grade glioma (HGG) cases, respectively. Two cohorts were constructed, one from 15,321 FDR of LGG cases and the other from 26,635 FDR of HGG cases calculating standardised incidence ratios (SIR). The risk for LGG among FDR of LGG cases was significantly increased, SIR 3.65 (95% CI 2.31-5.47). The risk was even higher in the cohort of siblings, SIR 7.00 (95% CI 3.35-12.87), and especially in the younger siblings (<40 years), SIR 9.01 (95% CI 4.31-16.57). When calculating the risk for HGG in the LGG cohort and the risk for HGG in the HGG cohort, there was a generally twofold increased risk, but no trends of increased risk in relatives of younger probands. Two different methods calculating familial risk displayed similar results. LGG families apparently have features manifesting a distinct pedigree pattern with sibpairs affected at a young age. These families could provide new insights into the aetiology of glioma.
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes.
Nakase T, Guerra G, Ostrom Q, Ge T, Melin B, Wrensch M Neuro Oncol. 2024; 26(10):1933-1944.
PMID: 38916140 PMC: 11448969. DOI: 10.1093/neuonc/noae112.
Nurminen R, Afyounian E, Paunu N, Katainen R, Isomaki M, Nurminen A Sci Rep. 2024; 14(1):11562.
PMID: 38773237 PMC: 11109329. DOI: 10.1038/s41598-024-62296-5.
Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes.
Nakase T, Guerra G, Ostrom Q, Ge T, Melin B, Wrensch M medRxiv. 2024; .
PMID: 38260701 PMC: 10802631. DOI: 10.1101/2024.01.10.24301112.
Alanen E, Heikkinen S, Nurminen R, Nykter M, Haapasalo H, Hirvonen E Neurooncol Adv. 2023; 5(1):vdad008.
PMID: 36950216 PMC: 10025807. DOI: 10.1093/noajnl/vdad008.
The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies.
Zou P, Gu A, Ji G, Zhao L, Zhao P, Lu A BMC Cancer. 2012; 12:7.
PMID: 22221621 PMC: 3329415. DOI: 10.1186/1471-2407-12-7.